Upload
kosey
View
36
Download
4
Embed Size (px)
DESCRIPTION
EVALUATION OF AS PATIENTS. YEAR 2005. GENERAL DEMOGRAPHICS GENDER. PATIENTS’ AGE GROUPS. DURATION OF DISEASE AGE. DIFFERENCE OF MS AT POSTTREATMENT. DIFFERENCE OF VAS ( PAIN ) AT POSTTREATMENT. DIFFERENCE OF OWB AT POSTTREATMENT. DIFFERENCE OF MHAQ AT POSTTREATMENT. - PowerPoint PPT Presentation
Citation preview
EVALUATION OF AS PATIENTSEVALUATION OF AS PATIENTS
YEAR 2005YEAR 2005
GENERAL DEMOGRAPHICSGENERAL DEMOGRAPHICSGENDERGENDER
♀ ♀ %% ♂♂ %% Total Total
ASAS 147147 35,335,3 269269 64,764,7 416416
PATIENTS’ AGE GROUPSPATIENTS’ AGE GROUPS
-20-20 %%21-21-4040 %%
41-41-6060 %% 61+61+ %% Mean Mean
ASAS 00 00 8080 19,219,2 281281 67,567,5 5555 13,313,3 49,749,7
DURATION OF DISEASE AGEDURATION OF DISEASE AGE
-10-10 %%11-11-2020 %%
21-21-3030 %% 31+31+ %% MeanMean
ASAS 122122 29,329,3 156156 37,537,5 101101 24,324,33737
8,98,9 16,916,9
DIFFERENCE OF MS DIFFERENCE OF MS AT POSTTREATMENTAT POSTTREATMENT
MS1MS1
--
MS2MS2
Dec Dec %% IncInc %% SameSame %%
ASAS 359359 86,386,3 1717 4,14,1 4040 9,69,6
MEANMEAN MS1MS1 MS2MS2
ASAS 5959 21,721,7
DIFFERENCE OF VAS ( PAIN ) DIFFERENCE OF VAS ( PAIN ) AT POSTTREATMENTAT POSTTREATMENT
VAS1VAS1
--
VAS2VAS2
(pain)(pain)
Dec Dec %% IncInc %% SameSame %%
ASAS 378378 90,990,9 3434 8,18,1 44 11
MEANMEAN VAS1VAS1 VAS2VAS2
ASAS 47,447,4 18,318,3
DIFFERENCE OF OWB DIFFERENCE OF OWB AT POSTTREATMENTAT POSTTREATMENT
OWB1OWB1
--
OWB2OWB2
Dec Dec %% IncInc %% SameSame %%
ASAS 387387 92,892,8 2424 5,75,7 66 1,51,5
MEANMEAN OWB1OWB1 OWB2OWB2
ASAS 51,851,8 19,919,9
DIFFERENCE OF MHAQ DIFFERENCE OF MHAQ AT POSTTREATMENTAT POSTTREATMENT
MHAQ1MHAQ1
--
MHAQ2MHAQ2
Dec Dec %% IncInc %% SameSame %%
ASAS 338338 81,281,2 1919 4,54,5 5959 14,314,3
MEANMEAN MHAQ1MHAQ1 MHAQ2MHAQ2
ASAS 15,1815,18 11,6411,64
DIFFERENCE OF BASFI DIFFERENCE OF BASFI AT POSTTREATMENTAT POSTTREATMENT
BASFI1BASFI1
--
BASFI2BASFI2Dec Dec %% IncInc %% SameSame %%
ASAS 394394 94,794,7 1818 4,34,3 44 11
MEANMEAN BASFI1BASFI1 BASFI2BASFI2
ASAS 39,2439,24 17,5117,51
DIFFERENCE OF BASDAI DIFFERENCE OF BASDAI AT POSTTREATMENTAT POSTTREATMENT
BASDAI1BASDAI1
--
BASDAI2BASDAI2Dec Dec %% IncInc %% SameSame %%
ASAS 391391 9494 2424 5,75,7 11 0,30,3
MEANMEAN BASDAI1BASDAI1 BASDAI2BASDAI2
ASAS 44,244,2 17,6517,65
DIFFERENCE OF SCHOBERDIFFERENCE OF SCHOBERAT POSTTREATMENTAT POSTTREATMENT
SCHB1SCHB1
--
SCHB2SCHB2Dec Dec %% IncInc %% SameSame %%
ASAS 2121 5,15,1 267267 64,264,2 128128 30,730,7
MEANMEAN SCHB1SCHB1 SCHB2SCHB2
ASAS 31,2531,25 36,6736,67
DIFFERENCE OF Thorax Expansion DIFFERENCE OF Thorax Expansion AT POSTTREATMENTAT POSTTREATMENT
ThExp1ThExp1
--
ThExp2ThExp2Dec Dec %% IncInc %% SameSame %%
ASAS 1313 3,13,1 366366 8888 3737 8,98,9
MEANMEAN ThExp1ThExp1 ThExp2ThExp2
ASAS 34,334,3 48,6648,66
DIFFERENCE OF Wall-Occiput DistanceDIFFERENCE OF Wall-Occiput DistanceAT POSTTREATMENTAT POSTTREATMENT
WO1WO1
--
WO2WO2Dec Dec %% IncInc %% SameSame %%
ASAS 247247 59,459,4 55 1,21,2 165165 39,439,4
MEANMEAN WO1WO1 WO2WO2
ASAS 55,955,9 37,4837,48
ANALGESIC USAGE ANALGESIC USAGE AT PRETREATMENTAT PRETREATMENT
AA A-A- %% A+A+ %%
ASAS 266266 63,9463,94 150150 36,0536,05
DIFFERENCE OF “A” USAGE AT DIFFERENCE OF “A” USAGE AT POSTTREATMENTPOSTTREATMENT
AA SameSame %% Dec Dec %% IncInc %% Sep Sep %%
ASAS 6969 4646 5353 35,335,3 66 44 2222 14,714,7
NSAID USAGE NSAID USAGE AT PRETREATMENTAT PRETREATMENT
NSAIDNSAID NSAID-NSAID- %% NSAID+NSAID+ %%
ASAS 126126 30,330,3 290290 69,769,7
DIFFERENCE OF NSAID USAGE DIFFERENCE OF NSAID USAGE AT POST-TREATMENTAT POST-TREATMENT
NSAIDNSAID SameSame %%Dec Dec
%% IncInc %% Sep Sep %%
ASAS 169169 58,358,3 7777 26,526,5 22 0,70,7 4242 14,514,5
STEROID USAGE STEROID USAGE AT PRE-TREATMENTAT PRE-TREATMENT
STRSTR STR-STR- %% STR+STR+ %%
ASAS 392392 94,294,2 2424 5,85,8
DIFFERENCE OF “STR” USAGE DIFFERENCE OF “STR” USAGE AT POSTTREATMENTAT POSTTREATMENT
STRSTR SameSame %% Dec Dec %% IncInc %% Sep Sep %%
ASAS 1717 70,870,8 33 12,512,5 11 4,24,2 33 12,512,5
USAGE OF OTHER DRUGS USAGE OF OTHER DRUGS AT PRETREATMENTAT PRETREATMENT
OTHOTH OTHER-OTHER- %% OTHER+OTHER+ %%
ASAS 313313 75,375,3 103103 24,724,7
DIFFERENCE OF OTHER DRUGS DIFFERENCE OF OTHER DRUGS AT POSTTREATMENTAT POSTTREATMENT
OTHOTH SameSame %% Dec Dec %% IncInc %% Sep Sep %%
ASAS 9999 96,296,2 44 3,83,8 00 00 00 00
MOSTLY SEEN MOSTLY SEEN SECONDARY DISEASESSECONDARY DISEASES
SEC.SEC.
DIS.DIS.
NONO
%%
YESYES
%%
HTHT
%%
CADCAD
%%
DMDM
%%COLDCOLD
%%
CACA
%%DEPRDEPR
%%
TROITROI
%%
OTHOTH
%%
ASAS172172
41,3441,34
244244
58,6558,65
7171
29,0929,09
2121
8,68,6
1414
5,735,73
2525
10,2410,24
88
3,273,27
88
3,273,27
2222
9,019,01
140140
57,3757,37
DAILY POLICLINIC CASESDAILY POLICLINIC CASES
POLIPOLICLNCLN
NONO
%%
YESYES
%%
TRATRA
%%
EYEEYE
%%
URSURS
%%
DERDER
%%
DIARDIAR
%%
PAINPAIN
%%
USEUSE
%%
OTHOTH
%%
ASAS284284
68,2668,26
132132
31,7331,73
66
4,544,54
99
6,816,81
2222
16,6616,66
99
6,816,81
1313
9,849,84
6060
45,4545,45
11
0,750,75
2929
21,9621,96
PATIENTS WHO WERE PATIENTS WHO WERE REFERRED TO HOSPITALREFERRED TO HOSPITAL
CONCONSULTSULT
NONO
%%
MRMR
%%
EYEEYE
%%
ENTENT
%%DERDER
%%
ORTORT
%%
NEUNEU
%%
ASAS405405
97,3597,35
11
0,240,24
33
0,720,72
11
0,240,24
11
0,240,24
22
0,480,48
33
0,720,72
THANK YOU THANK YOU
FOR YOUR ATTENTIONFOR YOUR ATTENTION